Skip to main content

Triple-negative breast cancer clinical trial

breast cancer cells

We are calling for volunteers for a clinical trial that aims to improve survival rates for patients with triple-negative breast cancer, a treatment-resistant form of cancer that can quickly adapt against chemotherapy.

Led by Associate Professor Christine Chaffer, the 4CAST clinical trial is testing a new combination therapy to target a ‘defence switch’ on cancer cells that alerts cancer to the threat of chemotherapy. The trial is being conducted at The Kinghorn Cancer Centre in Darlinghurst.

For further information about the trial NCT04947189) or to register your interest, please email St Vincent’s Hospital Sydney Research Office,

The research has ethics approval from St Vincent’s Hospital Human Research Ethics Committee (HREC 2020/ETH03307).